Selumetinib

CAS 606143-52-6

In Stock

Selumetinib

Cat. No. STUB-API-SELUMETINIBCAS 606143-52-6In Stock

Technical Data

Cat. No.STUB-API-SELUMETINIB

CAS606143-52-6

Mol. FormulaC₁₇H₁₅BrClFN₄O₃

Mol. Weight457.687 g/mol

IUPAC6-(4-bromo-2-chloroanilino)-7-fluoro-N-(2-hydroxyethoxy)-3-methylbenzimidazole-5-carboxamide

SMILESCN1C=NC2=C1C=C(C(=C2F)NC3=C(C=C(C=C3)Br)Cl)C(=O)NOCCO

InChIInChI=1S/C17H15BrClFN4O3/c1-24-8-21-16-13(24)7-10(17(26)23-27-5-4-25)15(14(16)20)22-12-3-2-9(18)6-11(12)19/h2-3,6-8,22,25H,4-5H2,1H3,(H,23,26)

InChI KeyCYOHGALHFOKKQC-UHFFFAOYSA-N

Purity—

Description

Overview

Selumetinib was originally developed as a treatment for cancers like melanoma, pancreatic cancer, colorectal cancer, and non-small cell lung

Anant Labs manufacture and furnish high quality Selumetinib impurities for global markets. Our Selumetinib EP Impurities are used by API manufacturers and fully integrated pharmaceutical companies worldwide.

Synonyms

Selumetinib606143-52-6AZD6244ARRY-1428865-[(4-BROMO-2-CHLOROPHENYL)AMINO]-4-FLUORO-N-(2-HYDROXYETHOXY)-1-METHYL-1H-BENZIMIDAZOLE-6-CARBOXAMIDEAZD 6244AZD-6244ARRY-886selumetinibumDTXSID3048944

Browse APIs A–Z